C2i Genomics, Premier: AI-centric oncology technology
Cancer intelligence firm C2i and healthcare firm Premier have announced a partnership to use artificial intelligence (AI) to uncover oncology insights. Among the goals of the collaboration is establishing a real-world evidence (RWE) council, and creating a whitepaper that addresses best practices in point-of-care solutions.
“By deploying the C2-Intelligence Platform to Premier’s broad network of provider settings, we have the potential to make real differences in the lives of patients,” said Asaf Zviran, co-founder and CEO of C2i Genomics. “We’re also excited to see what new insights and treatment efficiencies we can unlock by combining our rich data sets.”
